Healthequity (HQY) EBITDA (2013 - 2026)
Healthequity (HQY) EBITDA from Jul 31, 2013 to Apr 30, 2026. The TTM Healthequity (HQY) EBITDA is $496M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Healthequity (HQY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +35.63% |
| 3 Years TTM | +35.34% |
| 5 Years TTM | +28.20% |
| 10 Years TTM | +28.26% |
| All Time TTM | +34.20% |
Annual EBITDA change of Healthequity (HQY)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $477M | +46.90% |
| 2025 | $325M | +19.95% |
| 2024 | $271M | +59.04% |
| 2023 | $170M | -2855.02% |
| 2022 | -$6.18M | -32.24% |
| 2021 | -$9.12M | -106.89% |
| 2020 | $132M | +38.08% |
| 2019 | $96M | +449.97% |
| 2018 | $17M | +32.35% |
| 2017 | $13M | +49.83% |
| 2016 | $8.79M | +36.70% |
| 2015 | $6.43M | +54.94% |
| 2014 | $4.15M | +27.30% |
| 2013 | $3.26M | N/A |
Comparison Healthequity (HQY) five years EBITDA CAGR with competitors
Healthequity (HQY) five years EBITDA CAGR is 28.20%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| OPRX | OptimizeRx Corp | 77.72% | +175.60% |
| CCLD | CareCloud Inc | 73.90% | +162.04% |
| CCLDO | CareCloud Inc | 73.90% | +162.04% |
| SY | So-Young International Inc | 39.98% | +41.76% |
| DOCS | Doximity Inc - Class A | 32.10% | +13.82% |
| VEEV | Veeva Systems Inc - Class A | 23.79% | -15.64% |
| HCAT | Health Catalyst Inc | 20.13% | -28.60% |
| SDGR | Schrodinger Inc | 18.03% | -36.06% |
| PRVA | Privia Health Group Inc | 10.68% | -62.15% |
| EVH | Evolent Health Inc - Class A | 9.64% | -65.83% |
| SOPH | SOPHiA Genetics SA | 9.32% | -66.96% |
| HSTM | Healthstream Inc | 9.04% | -67.95% |
| SLP | Simulations Plus Inc | 2.64% | -90.64% |
| OMCL | Omnicell Inc | 0.63% | -97.77% |
| DRIO | DarioHealth Corp | 0.22% | -99.22% |